HHLA2 and metastatic neoplasm: An additional two specimens obtained at the time of initial biopsy, 17 specimens obtained at the time of definitive surgery, and five metastatic tumor specimens were available for analysis of HHLA2 and TILs, did not have either associated clinical outcome or demographic data.